Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

Parodis, I., Lindblom, J., Levy, R. A., Zen, M., Cetrez, N., Gomez, A., Oon, S., Henning, C., Khamashta, M., Quasny, H. A., Chauhan, D., Askanase, A., van Vollenhoven, R., & Nikpour, M. (2024). Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials. The Lancet Rheumatology. https://doi.org/10.1016/s2665-9913(24)00162-0
Authors:
Ioannis Parodis
Julius Lindblom
Roger A Levy
Margherita Zen
Nursen Cetrez
Alvaro Gomez
Shereen Oon
Christine Henning
Munther Khamashta
Holly A Quasny
Deven Chauhan
Anca Askanase
Ronald van Vollenhoven
Mandana Nikpour
Affiliated Authors:
Anca Askanase
Publication Type:
Article
Unique ID:
10.1016/s2665-9913(24)00162-0
PMID:
Publication Date:
Data Source:
PubMed

Record Created: